These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28524164)

  • 1. RIPped for neuroinflammation.
    Tummers B; Green DR
    Cell Res; 2017 Sep; 27(9):1081-1082. PubMed ID: 28524164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.
    Daniels BP; Snyder AG; Olsen TM; Orozco S; Oguin TH; Tait SWG; Martinez J; Gale M; Loo YM; Oberst A
    Cell; 2017 Apr; 169(2):301-313.e11. PubMed ID: 28366204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.
    Moriwaki K; Chan FK
    Int Rev Cell Mol Biol; 2017; 328():253-275. PubMed ID: 28069136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
    Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
    Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.
    Rucker AJ; Chan FK
    Trends Biochem Sci; 2022 Apr; 47(4):342-351. PubMed ID: 34998669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Alveolar Epithelial Cell Necroptosis in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Lee JM; Yoshida M; Kim MS; Lee JH; Baek AR; Jang AS; Kim DJ; Minagawa S; Chin SS; Park CS; Kuwano K; Park SW; Araya J
    Am J Respir Cell Mol Biol; 2018 Aug; 59(2):215-224. PubMed ID: 29444413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK3: Beyond Necroptosis.
    Evans AS; Coyne CB
    Immunity; 2019 Jan; 50(1):1-3. PubMed ID: 30650369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Receptor Interacting Protein Kinases in the Liver.
    Dara L
    Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diverse role of RIP kinases in necroptosis and inflammation.
    Silke J; Rickard JA; Gerlic M
    Nat Immunol; 2015 Jul; 16(7):689-97. PubMed ID: 26086143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
    Wegner KW; Saleh D; Degterev A
    Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIPK3 Mediates Necroptosis during Embryonic Development and Postnatal Inflammation in Fadd-Deficient Mice.
    Zhao Q; Yu X; Zhang H; Liu Y; Zhang X; Wu X; Xie Q; Li M; Ying H; Zhang H
    Cell Rep; 2017 Apr; 19(4):798-808. PubMed ID: 28445730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
    Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W
    Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis in development, inflammation and disease.
    Weinlich R; Oberst A; Beere HM; Green DR
    Nat Rev Mol Cell Biol; 2017 Feb; 18(2):127-136. PubMed ID: 27999438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.